Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study

4 Feb 2026 Uncategorized

VAC4EU sets standard for harmonised case validation in real-world data studies

Our most recent open-source paper was published last week in Clinical Epidemiology! The article describes how VAC4EU developed a scalable pipeline for outcome validation using Brighton...

Uncertainty in science: Should we say more, or less? New Journal Club session 21 January

A more scientifically literate public enables better engagement and understanding on complex socioscientific issues like COVID-19 or climate change. But...

VAC4EU celebrates 5 years: Reflections and future directions

On the 4th of November 2025, 150 people came together both online and in Brussels for a milestone event celebrating the 5th anniversary of VAC4EU....

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases – an ACCESS cohort study

Contact

About VAC4EU

Organization

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases – an ACCESS cohort study

Related posts

VAC4EU sets standard for harmonised case validation in real-world data studies

Uncertainty in science: Should we say more, or less? New Journal Club session 21 January

VAC4EU celebrates 5 years: Reflections and future directions

Join our community